BDBM805309 US20260125379, Compound B11

SMILES N#CC[C@H]1CC[C@H](n2c(/N=N/c3ccc(O)c(C(=O)N[C@H](C/N=C(\N)O)C(=O)O)c3)nc3cnc4[nH]ccc4c32)CC1

InChI Key InChIKey=OCQAIJQJFHDWCE-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 805309   

TargetTyrosine-protein kinase JAK1(Human)
E-Nitiate Biopharmaceuticals (Hangzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 805309BDBM805309(US20260125379, Compound B11)
Affinity DataIC50: 1.60nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/17/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
E-Nitiate Biopharmaceuticals (Hangzhou) Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 805309BDBM805309(US20260125379, Compound B11)
Affinity DataIC50: 3.38nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/17/2026
Entry Details
US Patent